{"id":"https://openalex.org/W7165873055","doi":"https://doi.org/10.32604/or.2026.080161","title":"Immunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations","display_name":"Immunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7165873055","doi":"https://doi.org/10.32604/or.2026.080161","pmid":"https://pubmed.ncbi.nlm.nih.gov/42984928","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13732326"},"language":"en","primary_location":{"id":"doi:10.32604/or.2026.080161","doi":"https://doi.org/10.32604/or.2026.080161","is_oa":true,"landing_page_url":"https://doi.org/10.32604/or.2026.080161","pdf_url":"https://www.techscience.com/or/online/detail/27322/pdf","source":{"id":"https://openalex.org/S146643948","display_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","issn_l":"0965-0407","issn":["0965-0407","1555-3906"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4360969325","host_organization_name":"Cognizant Communication Corporation","host_organization_lineage":["https://openalex.org/P4360969325"],"host_organization_lineage_names":["Cognizant Communication Corporation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.techscience.com/or/online/detail/27322/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5139305742","display_name":"Lila A. Marshall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lila A. Marshall","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Irvine, Orange, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Irvine, Orange, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040012879","display_name":"Natalie L. Ayoub","orcid":"https://orcid.org/0000-0003-2931-5834","observed_orcids":["https://orcid.org/0000-0003-2931-5834"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie L. Ayoub","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Irvine, Orange, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Irvine, Orange, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110911403","display_name":"Jill Tseng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jill Tseng","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Irvine, Orange, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Irvine, Orange, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028546561","display_name":"Alex Francoeur","orcid":"https://orcid.org/0000-0001-8606-6817","observed_orcids":["https://orcid.org/0000-0001-8606-6817"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex A. Francoeur","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Irvine, Orange, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Irvine, Orange, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5139305742"],"corresponding_institution_ids":["https://openalex.org/I204250578"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24219698,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"11","first_page":"1","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.902999997138977},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.9419999718666077},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.9179999828338623},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7860000133514404},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7900000214576721},{"id":"https://openalex.org/keywords/ovarian-clear-cell-carcinoma","display_name":"ovarian clear cell carcinoma","score":0.8149999976158142},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8123000264167786},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6787999868392944},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.626800000667572},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5521000027656555},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5501000285148621},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5236999988555908},{"id":"https://openalex.org/C2992773878","wikidata":"https://www.wikidata.org/wiki/Q7645976","display_name":"Epithelial ovarian cancer","level":4,"score":0.4422000050544739},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39910000562667847},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38589999079704285},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.3598000109195709},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.35089999437332153},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3407000005245209},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.32030001282691956},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.31679999828338623},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.31200000643730164},{"id":"https://openalex.org/C185926286","wikidata":"https://www.wikidata.org/wiki/Q1929812","display_name":"Systemic therapy","level":4,"score":0.3075999915599823},{"id":"https://openalex.org/C140608501","wikidata":"https://www.wikidata.org/wiki/Q7318358","display_name":"Review article","level":2,"score":0.30390000343322754},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2784999907016754},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2718999981880188},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2718999981880188},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.26089999079704285},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.25859999656677246},{"id":"https://openalex.org/C148482608","wikidata":"https://www.wikidata.org/wiki/Q17007018","display_name":"Clinical study design","level":3,"score":0.25360000133514404}],"mesh":[{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.32604/or.2026.080161","doi":"https://doi.org/10.32604/or.2026.080161","is_oa":true,"landing_page_url":"https://doi.org/10.32604/or.2026.080161","pdf_url":"https://www.techscience.com/or/online/detail/27322/pdf","source":{"id":"https://openalex.org/S146643948","display_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","issn_l":"0965-0407","issn":["0965-0407","1555-3906"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4360969325","host_organization_name":"Cognizant Communication Corporation","host_organization_lineage":["https://openalex.org/P4360969325"],"host_organization_lineage_names":["Cognizant Communication Corporation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13732326","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13732326/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13732326/pdf/OncolRes-34-80161.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncol Res","raw_type":"Text"},{"id":"pmid:42984928","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42984928","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.32604/or.2026.080161","doi":"https://doi.org/10.32604/or.2026.080161","is_oa":true,"landing_page_url":"https://doi.org/10.32604/or.2026.080161","pdf_url":"https://www.techscience.com/or/online/detail/27322/pdf","source":{"id":"https://openalex.org/S146643948","display_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","issn_l":"0965-0407","issn":["0965-0407","1555-3906"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4360969325","host_organization_name":"Cognizant Communication Corporation","host_organization_lineage":["https://openalex.org/P4360969325"],"host_organization_lineage_names":["Cognizant Communication Corporation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7165873055.pdf","grobid_xml":"https://content.openalex.org/works/W7165873055.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4294265841","https://openalex.org/W3011954154","https://openalex.org/W7168137347","https://openalex.org/W3152457861","https://openalex.org/W4200026234","https://openalex.org/W4225679035","https://openalex.org/W2503593215","https://openalex.org/W7163210489","https://openalex.org/W3039640792","https://openalex.org/W7134257120"],"abstract_inverted_index":{"Epithelial":[0],"ovarian":[1,113,231],"cancer":[2,131,232],"(EOC)":[3],"is":[4,13,211],"most":[5,170],"commonly":[6],"diagnosed":[7],"at":[8],"an":[9],"advanced":[10],"stage":[11],"and":[12,33,65,133,151,201,233,237],"known":[14],"to":[15,23,39,61,175,184,212,222],"recur":[16],"frequently.":[17],"Recurrent":[18],"EOC":[19,100],"can":[20],"be":[21],"difficult":[22,38],"treat,":[24,40],"with":[25,41,58],"limited":[26,66],"effective":[27],"options":[28,45],"for":[29,47,168,239],"systemic":[30,63],"therapy.":[31],"Platinum-resistant":[32],"-refractory":[34],"recurrences":[35],"are":[36,54,116],"particularly":[37],"even":[42],"fewer":[43],"therapeutic":[44],"than":[46],"platinum-sensitive":[48],"recurrences.":[49],"Less":[50],"common":[51],"histologic":[52],"subtypes":[53],"also":[55,163],"challenging,":[56],"often":[57],"poor":[59],"responses":[60],"typical":[62],"therapies":[64],"clinical":[67,108,139],"trial":[68],"data.":[69],"With":[70],"successes":[71],"in":[72,78,89,96,112,130,149,157,227,242,247],"the":[73,92,97,106,124,127,142,153,158,165,190,215,223,228,235,243],"use":[74,143,159,224,244],"of":[75,81,94,99,105,126,136,144,155,160,208,218,225,230,245],"immunotherapy":[76],"(IO)":[77],"other":[79,180],"types":[80],"solid":[82,181],"tumors,":[83],"IO":[84,95,111,134,226,246],"has":[85,101],"been":[86],"investigated":[87],"extensively":[88],"EOC.":[90,248],"However,":[91],"incorporation":[93],"treatment":[98,229],"yielded":[102],"variable":[103],"results;":[104],"many":[107],"trials":[109,140],"studying":[110],"cancer,":[114],"there":[115],"very":[117],"few":[118],"positive":[119],"results.":[120],"This":[121],"article":[122],"discusses":[123],"role":[125,154],"immune":[128,145],"system":[129],"proliferation":[132],"mechanisms":[135],"action,":[137],"reviews":[138],"involving":[141],"checkpoint":[146],"inhibition":[147],"(ICI)":[148],"EOC,":[150],"considers":[152],"biomarkers":[156],"IO.":[161],"We":[162],"discuss":[164,189],"possible":[166],"reasons":[167],"why":[169],"EOCs":[171,191],"do":[172,183],"not":[173],"seem":[174],"respond":[176],"as":[177,179,186,188],"well":[178,187],"tumors":[182],"IO,":[185],"that":[192],"have":[193],"shown":[194],"more":[195],"promising":[196],"responses,":[197],"namely":[198],"platinum-resistant":[199],"disease":[200],"clear":[202],"cell":[203],"histology.":[204],"The":[205],"overarching":[206],"aim":[207],"this":[209],"review":[210],"comprehensively":[213],"digest":[214],"large":[216],"volume":[217],"existing":[219],"research":[220],"pertaining":[221],"examine":[234],"pitfalls":[236],"possibilities":[238],"future":[240],"success":[241]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-06-26T00:00:00"}